Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Middle East Coronary Artery Ectasia Registry (MECAER): Incidence, Management, and One-Year Prognosis: A Multi-Centre Prospective Cohort Study.

NCT05213429 is registered in ClinicalTrials.gov with Jordanian Research and Artificial Intelligence Group as lead sponsor.

NCT NCT05213429
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05213429 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Middle East Coronary Artery Ectasia Registry (MECAER): Incidence, Management, and One-Year Prognosis: A Multi-Centre Prospective Cohort Study.
Lead sponsor
Jordanian Research and Artificial Intelligence Group
Phase
Observational
Overall status
Recruiting
Start date
September 1, 2024
Completion date
December 31, 2027
Enrollment
11,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery ectasia